Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ·Healthcare·Biotechnology
$34.75
+3.64%
Mkt Cap $3.54B
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (21 analysts)
$86.60
Range $67.00 – $105.00
Implied Upside
+149.2%
Consensus $86.60 vs current $34.75